105
Participants
Start Date
January 1, 2021
Primary Completion Date
January 1, 2022
Study Completion Date
January 1, 2023
Aspirin
The patients received aspirin in a dose of 100 mg orally daily.
Ketorolac
The patients received ketorolac in a dose of 90 mg mg orally daily.
Celecoxib
The patients received celecoxib in a dose of 400 mg orally daily.
Federal Center for Traumatology, Orthopedics and Endoprosthetics, Cheboksary
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty
OTHER